Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gabriela Hobbs, M.D.

Concepts (288)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Polycythemia Vera1020221634.760 Why?
Myeloproliferative Disorders1820236034.610 Why?
Thrombocythemia, Essential720221033.970 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive920236893.610 Why?
Primary Myelofibrosis1020242143.490 Why?
Blast Crisis320211032.130 Why?
Leukemia, Myeloid, Chronic-Phase32021381.140 Why?
Protein Kinase Inhibitors10202355221.050 Why?
Leukemia, Myeloid, Acute16202334970.920 Why?
Pregnancy Complications, Hematologic220211830.830 Why?
STAT Transcription Factors320191820.770 Why?
Hypereosinophilic Syndrome12021930.760 Why?
Janus Kinase 2520215270.680 Why?
Thrombosis2202329660.630 Why?
Antigens, CD19120203790.610 Why?
Janus Kinases220192440.600 Why?
Neoplasms92023215960.600 Why?
Splenomegaly120171900.590 Why?
Live Birth120205120.570 Why?
Antineoplastic Combined Chemotherapy Protocols112022114720.530 Why?
Oncogene Proteins, Fusion5202215810.520 Why?
Abortion, Spontaneous120205420.520 Why?
HSP90 Heat-Shock Proteins120174340.500 Why?
Atrial Fibrillation2202350190.490 Why?
Sleep Initiation and Maintenance Disorders120239970.480 Why?
Venous Thromboembolism2202316680.470 Why?
Hematopoietic Stem Cell Transplantation6202354250.460 Why?
Fatigue1202015260.440 Why?
Hypertension, Pulmonary1202315270.430 Why?
Antineoplastic Agents72022136550.420 Why?
Venous Thrombosis1202112370.410 Why?
Immunotherapy, Adoptive1202012550.400 Why?
Disease Management5202124500.370 Why?
Stroke2202399630.370 Why?
Molecular Targeted Therapy3201827230.350 Why?
Pyrimidines8202429330.350 Why?
Medical Oncology6202222350.330 Why?
Humans7620247420880.320 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma3202215150.310 Why?
Pyrazoles7202419700.310 Why?
Nitriles520249520.310 Why?
Patient Preference120158860.310 Why?
Philadelphia Chromosome420201120.290 Why?
Hemorrhage3202334610.280 Why?
Hematologic Neoplasms4202218200.280 Why?
Azepines220193360.280 Why?
Eosinophilia220205310.270 Why?
Pyrrolidines220243420.250 Why?
Thrombocytopenia2202211710.250 Why?
Mutation122021297170.240 Why?
Genetic Predisposition to Disease32021174000.240 Why?
Models, Biological1202095810.240 Why?
Family1201531440.230 Why?
Leukemia2202215070.220 Why?
Phlebotomy220211420.220 Why?
Prognosis122020290100.220 Why?
Cytarabine620196840.210 Why?
Patient Satisfaction1201533910.210 Why?
Decision Making2201838690.210 Why?
Calreticulin22019970.200 Why?
Platelet Count220227800.200 Why?
Clinical Trials, Phase II as Topic320226270.200 Why?
Signal Transduction42019233870.190 Why?
Hematology120232190.180 Why?
Risk Factors82023721450.170 Why?
Chemokine CXCL10120203040.170 Why?
Niacinamide120214160.170 Why?
RNA Helicases120201420.170 Why?
Middle Aged2320222131270.170 Why?
Receptor, Platelet-Derived Growth Factor beta120201880.170 Why?
Interferons120227040.160 Why?
Thrombocytosis12018810.160 Why?
Heart Failure12022108560.160 Why?
Female2920233795920.160 Why?
Aged2320231629440.160 Why?
Phenylurea Compounds120205260.150 Why?
Anticoagulants2202345950.150 Why?
Retrospective Studies112022770980.150 Why?
Pyridines2202028180.150 Why?
Mastocytosis, Systemic120181000.150 Why?
Glutarates120182360.150 Why?
Peripheral Blood Stem Cell Transplantation120182720.140 Why?
Risk Assessment72023233200.140 Why?
Spleen1202323590.140 Why?
Treatment Outcome102022629660.140 Why?
Male2720223495380.140 Why?
Leukemia, Myeloid120197050.140 Why?
Transplantation, Homologous3202047710.140 Why?
Anxiety4202342790.130 Why?
Transplantation Conditioning1202315970.130 Why?
Adult1920212137120.130 Why?
Antifungal Agents120207290.130 Why?
Colorectal Neoplasms1201567540.130 Why?
Young Adult102021563500.130 Why?
Research1202319990.120 Why?
Hospice Care120216710.120 Why?
Anilides120174040.120 Why?
Pregnancy Complications, Neoplastic120162530.120 Why?
DNA Helicases120208610.120 Why?
Abnormalities, Drug-Induced120163160.120 Why?
fms-Like Tyrosine Kinase 3120174910.120 Why?
Bradyrhizobium12013190.120 Why?
Interferon-beta120153230.120 Why?
Clinical Trials as Topic3201879010.110 Why?
Quality of Life72023127300.110 Why?
Drug Discovery1202110570.110 Why?
Stress Disorders, Post-Traumatic2202142480.110 Why?
Disease Susceptibility1202017800.110 Why?
Isocitrate Dehydrogenase120188700.110 Why?
Anemia1202214990.110 Why?
Remission Induction4202223840.110 Why?
Infection Control120209620.110 Why?
Respiratory Insufficiency1202111990.110 Why?
Immunoconjugates120198970.110 Why?
Aged, 80 and over92021576830.100 Why?
Maximum Tolerated Dose320198910.100 Why?
Fertility120167700.100 Why?
Drug Evaluation, Preclinical1201713720.100 Why?
Aspirin2202132780.100 Why?
Incidence52022209280.100 Why?
Chromosome Aberrations1201818110.100 Why?
Anaphylaxis120187460.100 Why?
Disease Progression42021132560.100 Why?
Boston2202193050.100 Why?
Affect1201914730.100 Why?
Disease-Free Survival2201968910.100 Why?
Patient Care Team2202025270.100 Why?
Cause of Death1202135710.090 Why?
Antibodies, Viral1202231640.090 Why?
Lung Neoplasms12015130190.090 Why?
Pregnancy32021290870.090 Why?
Opportunistic Infections120133890.090 Why?
Hospitalization32021102320.090 Why?
Needs Assessment1201611460.090 Why?
Point Mutation1201516240.090 Why?
Mortality1202128570.090 Why?
Polyethylene Glycols1201511810.090 Why?
Phosphoproteins1201824400.090 Why?
Terminal Care1202116880.090 Why?
Hospitals1202339370.090 Why?
Vaccination1202232560.090 Why?
Graft vs Host Disease2202029510.090 Why?
Patient Readmission1202331110.090 Why?
Stem Cell Transplantation1201816180.090 Why?
Myelodysplastic Syndromes1201913510.080 Why?
Immunologic Factors1201815750.080 Why?
Communicable Diseases120178780.080 Why?
Idarubicin22019620.080 Why?
Mitoxantrone220191490.080 Why?
Platelet Aggregation Inhibitors1202130670.080 Why?
Patient Admission1201613800.080 Why?
Carcinoma, Hepatocellular1202022110.080 Why?
Randomized Controlled Trials as Topic2202299410.080 Why?
Clinical Competence1202346810.080 Why?
Neoplasms, Second Primary1201510520.080 Why?
Acute Kidney Injury1202019670.070 Why?
Fusion Proteins, bcr-abl220204330.070 Why?
Etoposide220196370.070 Why?
Neoplasm Proteins1201936910.070 Why?
Survival Rate22018127730.070 Why?
Receptors, Thrombopoietin220191560.070 Why?
CD8-Positive T-Lymphocytes1202044380.070 Why?
Fetal Blood1201313170.070 Why?
Genotype12021129460.070 Why?
Enzyme Inhibitors1201738000.070 Why?
Age Factors22020183550.070 Why?
Genetic Variation1202165400.070 Why?
Intensive Care Units1201936790.070 Why?
Phenotype12023163310.070 Why?
Insurance Coverage1201718950.070 Why?
Practice Guidelines as Topic2202072760.070 Why?
Hospital Mortality1201953100.070 Why?
Colitis1201311490.060 Why?
Colon1201317730.060 Why?
Liver Neoplasms1202042490.060 Why?
In Situ Hybridization, Fluorescence2202226380.060 Why?
Insurance, Health1201724930.060 Why?
T-Lymphocytes12022101630.060 Why?
Phosphatidylinositol 3-Kinases2202429380.060 Why?
Follow-Up Studies42019390040.050 Why?
Coronavirus Infections1202031300.050 Why?
Pneumonia, Viral1202032360.050 Why?
Cohort Studies22021404500.050 Why?
SEER Program2201715070.050 Why?
Isoxazoles120222160.050 Why?
Nuclear Pore Complex Proteins120221650.050 Why?
Animals420211685610.050 Why?
Prospective Studies42021531870.050 Why?
Boron Compounds120221780.050 Why?
Surge Capacity12020420.050 Why?
Accreditation120234490.050 Why?
Acute Disease2202271410.050 Why?
Benzazepines120223260.050 Why?
North America1202312490.040 Why?
Vincristine1202210360.040 Why?
Drug Resistance, Neoplasm3201951630.040 Why?
Genes, sry1201850.040 Why?
Recurrence2202283330.040 Why?
mRNA Cleavage and Polyadenylation Factors12018980.040 Why?
Clinical Trials, Phase III as Topic120228390.040 Why?
Glycine120226710.040 Why?
Histamine Antagonists12018930.040 Why?
Bone Marrow2201829410.040 Why?
Cytogenetic Analysis120182950.040 Why?
Resource Allocation120203410.040 Why?
Workflow120228460.040 Why?
Expert Testimony120203560.040 Why?
Histocompatibility120183300.040 Why?
Drug Evaluation120186370.040 Why?
Death120216750.040 Why?
Anthracyclines120192880.040 Why?
Receptor, Platelet-Derived Growth Factor alpha120183790.040 Why?
World Health Organization1202213170.040 Why?
Societies, Medical2201837400.040 Why?
United States62021696930.040 Why?
Combined Modality Therapy2201886210.030 Why?
Transplantation Chimera120186120.030 Why?
Fibrosis1202220260.030 Why?
Marital Status120174370.030 Why?
Translocation, Genetic1202014170.030 Why?
Proto-Oncogene Proteins c-kit120187740.030 Why?
Biopsy2201867560.030 Why?
Survival Analysis22017102480.030 Why?
Hydroxyurea120152900.030 Why?
Delivery of Health Care2202253040.030 Why?
Immunophenotyping1201818660.030 Why?
Bone Marrow Cells1202125130.030 Why?
Administration, Oral1202139130.030 Why?
Proto-Oncogene Proteins c-akt1202225020.030 Why?
Palliative Care2202134780.030 Why?
Fatal Outcome1201818490.030 Why?
United States Food and Drug Administration1202115810.030 Why?
Cardiovascular Diseases12019151080.030 Why?
Physician's Role120209420.030 Why?
Consensus1202229350.030 Why?
Longitudinal Studies22019139210.030 Why?
Paraffin Embedding120132990.030 Why?
Withholding Treatment120165980.030 Why?
Antibiotic Prophylaxis120176380.030 Why?
Perception1201811880.030 Why?
Drug Administration Schedule1201949290.020 Why?
Depression2202377330.020 Why?
Medically Uninsured120178520.020 Why?
Mast Cells1201815440.020 Why?
Salvage Therapy1201712690.020 Why?
Education, Medical, Graduate1202322830.020 Why?
Adaptation, Psychological1202125750.020 Why?
Pilot Projects1202382970.020 Why?
Educational Status1201725330.020 Why?
Genome, Bacterial120137540.020 Why?
DNA, Bacterial1201314650.020 Why?
Hematopoietic Stem Cells1202133810.020 Why?
Income1201719040.020 Why?
Immunocompromised Host120138470.020 Why?
Social Class1201719950.020 Why?
Patient Acceptance of Health Care1202130140.020 Why?
Angiogenesis Inhibitors1201720380.020 Why?
Mice, Transgenic1201997350.020 Why?
Genomics1202256920.020 Why?
Immunotherapy1202244140.020 Why?
Diarrhea1201313430.020 Why?
Patient Selection1201842140.020 Why?
Phylogeny1201327970.020 Why?
Dose-Response Relationship, Drug12018109430.020 Why?
Poverty1201726460.020 Why?
Physician-Patient Relations1201832150.020 Why?
Population Surveillance1201526160.020 Why?
Evidence-Based Medicine1201636110.020 Why?
Logistic Models12019134030.020 Why?
Cell Line, Tumor12020166650.010 Why?
Medicaid1201727160.010 Why?
Polymerase Chain Reaction1201361710.010 Why?
Cell Differentiation12021114700.010 Why?
Odds Ratio1201698460.010 Why?
DNA Methylation1201742820.010 Why?
Multivariate Analysis12017122420.010 Why?
Mice22020810450.010 Why?
Immunohistochemistry12016113630.010 Why?
Proportional Hazards Models12017123440.010 Why?
Sequence Analysis, DNA1201348010.010 Why?
Databases, Factual1201777160.010 Why?
Disease Models, Animal12020180060.010 Why?
Colonic Neoplasms1201325420.010 Why?
Adolescent22021856490.010 Why?
Child22021774780.010 Why?
Pandemics1202083280.010 Why?
Prevalence12016151940.010 Why?
Time Factors12016400540.010 Why?
Hobbs's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (288)
Explore
_
Co-Authors (147)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.